Manus Bio
Manus Bio Inc. (trading as "Manus", the BioAlternatives Company) is a Cambridge, Massachusetts industrial biotechnology company founded in 2011 out of MIT by Dr. Aji Parayil and Dr. Greg Stephanopoulos. Manus engineers microbial cell factories and precision-fermentation processes so that complex molecules normally obtained through petrochemical synthesis, agricultural extraction, or animal husbandry can be produced by fermentation instead - what the company calls bioalternatives. Its commercialized products include the first U.S. commercial-scale monk fruit sweetener (produced at its Augusta, Georgia BioFacility), the Yume M stevia Reb M sweetener co-developed with Tate & Lyle, citrus-derived aroma ingredients (Nootkatone 70, Valencene 80, BioNootkatone) for Givaudan, and an artemisinin antimalarial program funded by HHS/ASPR. It sells scale-up services through its BioAccelerator and BioManufacturing programs (protein engineering, strain development, bioprocess development from 250 ml to 3,000 L, pilot-scale and biomanufacturing). In April 2025 Manus merged with genome-engineering company Inscripta, adding whole-genome editing technology and the MAD7 CRISPR nuclease licensing program; inscripta.com is now a redirect notice. Manus is a manufacturer of physical ingredients and a contract development and manufacturing organization - it sells molecules and services, not software. It publishes no public API, developer portal, SDK, webhook surface, or machine-readable specification of any kind, and its computational and AI-driven enzyme-engineering tools are internal capabilities that support its services rather than a customer-facing platform.
Manus Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Synthetic Biology, Biomanufacturing, and Industrial Biotechnology.
Manus Bio’s developer surface includes engineering blog and 8 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API